FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

10x Genomics, Inc. TXG

Promising (early)   broader-coverage candidate · Headquartered in Pleasanton, California, 10x Genomics, Inc.

On FrontierLab's discovery record since 2026-07-10 (6 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Promising (early)" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-08-21), not the curated Frontier signal.
Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.

Key quality signals

Revenue growth (YoY)-4.3%
Gross margin70%
Gross profits / assets0.42
Rule of 40-18.6
Net margin-14.3%
Cash runway (months)
PEG
Price / sales13.1

Quality checklist

Fundamentals — snapshot as of 2026-08-21

StageEarly
Share issuance (YoY)4.4% · modest issuance
Moat
TAM
P/E (trailing)
EPS (trailing)$-0.59
Burn multiple
Gross-margin trend (pts)0.5
Cash / assets0.54
Net debt / EBITDA-15.1
Statements as ofQ2 FY2026 · filed 2026-08-07

Momentum context — a snapshot from 2026-08-21, not current

Price at surface$63.87 (as of 2026-08-21)
52-week range$11.16 – $64.53
% off 52-wk high-1%
RSI (14)73
Relative volume

Risk flags

Burning cash — operating margin is negative.Parabolic one-day spike (+14%) in the last month — extreme single-day moves tend to mean-revert.

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-08-21 (end-of-day). How grades are computed →